机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Kunming, Yunnan, Peoples R China;昆明医科大学附属第一医院普通外一科(胃肠与疝外科)普通外科外科科室[2]Kunming Med Univ, Sch Publ Hlth, 1168th West Chunrong Rd, Kunming 650500, Yunnan, Peoples R China
Background: The Forkhead transcription family member FOXA2 plays a fundamental role in hepatocellular carcinoma ( HCC) progression, but the precise interaction factor and molecular regulation of FOXA2 are not fully understood. Objective: In this study, we found that FOXA2 could interact with sirtuin 6 ( SIRT6) directly in vivo and in vitro. We explored that the expressions of FOXA2 and SIRT6 were significantly downregulated in human HCC and HCC cell lines. Methods: Functionally, cell counting kit-8 assay and Transwell (R) assay were performed; we demonstrated that the knockdown of FOXA2 and SIRT6 promoted HepG2 cells and Huh7 cells proliferation and invasion in vitro. Results: Mechanically, using luciferase reporter assay and fast chromatin immunoprecipitation assay, we showed that FOXA2 and SIRT6 regulated the expression of ZEB2 from transcription level. ZEB2 suppression was involved in the anti-oncogenesis effect of FOXA2 and SIRT6. The negative correlation between the expressions of ZEB2 and FOXA2 or SIRT6 was observed in the tissues of HCC patients. Conclusion: Our findings indicated that the coordination function of FOXA2 and SIRT6 played a critical role in HCC progression and may serve as potential drug candidates for HCC.
第一作者机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Kunming, Yunnan, Peoples R China;
通讯作者:
通讯机构:[2]Kunming Med Univ, Sch Publ Hlth, 1168th West Chunrong Rd, Kunming 650500, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
Liu Jinghua,Yu Zhen,Xiao Yuanyuan,et al.Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition[J].CANCER MANAGEMENT AND RESEARCH.2018,10:391-401.doi:10.2147/CMAR.S150552.
APA:
Liu, Jinghua,Yu, Zhen,Xiao, Yuanyuan,Meng, Qiong,Wang, Yeying&Chang, Wei.(2018).Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition.CANCER MANAGEMENT AND RESEARCH,10,
MLA:
Liu, Jinghua,et al."Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition".CANCER MANAGEMENT AND RESEARCH 10.(2018):391-401